As of May 31, 2025, Senseonics Holdings Inc (SENS) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Senseonics Holdings Inc's Forward P/E to Peers
To better understand Senseonics Holdings Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Senseonics Holdings Inc (SENS) | - |
| Antares Pharma Inc (ATRS) | 51.85 |
| Meridian Bioscience Inc (VIVO) | 39.98 |
| Arch Therapeutics Inc (ARTH) | 0.01 |
Compared to its competitors, Senseonics Holdings Inc's Forward P/E is difficult to compare due to insufficient data.